Emerging Technologies in Liquid Biopsy of Cancers
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 47
Special Issue Editor
Special Issue Information
Dear Colleagues,
Liquid biopsy is revolutionizing the diagnosis and monitoring of cancer by enabling the non-invasive detection of tumor-derived biomarkers (e.g., ctDNA, CTCs, exosomes) in blood or other biofluids. This Special Issue explores cutting-edge technological advances in the field, with an emphasis on novel methodologies such as high-sensitivity detection platforms (single-cell analysis, microfluidics, CRISPR-based assays), multi-omics integration (fragmentomics, epigenomics, proteomics), and AI-driven bioinformatics pipelines; emerging biomarkers, with the discovery and validation of novel signatures (cfDNA fragmentation patterns, methylation profiles, metabolite panels) for early cancer detection, the monitoring of minimal residual disease, and the prediction of therapy resistance; and clinical translation, with developments addressing challenges such as low-abundance target isolation, the standardization of pre-analytical protocols, and longitudinal monitoring to accelerate clinical adoption. We welcome original research, reviews, and perspectives on in silico biomarker discovery, point-of-care devices, nanotechnology applications, and multi-modal liquid biopsy frameworks. Submissions should highlight technological novelty, analytical/clinical validation, and translational potential across solid and hematologic malignancies. This Special Issue invites innovators, clinical researchers, and biotech stakeholders to contribute to this Special Issue and shape the next generation of precision oncology tools.
Dr. Lingdi Yin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liquid biopsy
- circulating tumor cells (CTCs)
- circulating tumor DNA (ctDNA)
- exosomes
- cancer diagnostics
- biomarker discovery
- minimally invasive monitoring
- emerging technologies
- clinical translation
- molecular profiling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
